Abstract:Introduction: Progranulin (PGRN) is a secreted glycoprotein, the expression of which is linked to several neurodegenerative diseases. Although its specific function is still unclear, several studies have linked it with lysosomal functions and immune system regulation. Here, we have explored the role of PGRN in peripheral and central immune system homeostasis by investigating the consequences of PGRN deficiency on adaptive and innate immune cell populations. Methods: First, we used gene co-expression network analysis of published data to test the hypothesis that Grn has a critical role in regulating the activation status of immune cell populations in both central and peripheral compartments. To investigate the extent to which PGRN-deficiency resulted in immune dysregulation, we performed deep immunophenotyping by flow cytometry of 19-24-month old male and female Grn-deficient mice (PGRN KO) and littermate Grn-sufficient controls (WT). Results: Male PGRN KO mice exhibited a lower abundance of microglial cells with higher MHC-II expression, increased CD44 expression on monocytes in the brain, and more CNS-associated CD8+ T cells compared to WT mice. Furthermore, we observed an increase in CD44 on CD8+ T cells in the peripheral blood. Female PGRN KO mice also had fewer microglia compared to WT mice, and we also observed reduced expression of MHC-II on brain monocytes. Additionally, we found an increase in Ly-6Chigh monocyte frequency and decreased CD44 expression on CD8+ and CD4+ T cells in PGRN KO female blood. Given that Gpnmb, which encodes for the lysosomal protein Glycoprotein non-metastatic melanoma protein B, has been reported to be upregulated in PGRN KO mice, we investigated changes in GPNMB protein expression associated with PGRN deficits and found that GPNMB is modulated in myeloid cells in a sex-specific manner. Discussion: Our data suggest that PGRN and GPNMB jointly regulate the peripheral and the central immune system in a sex-specific manner; thus, understanding their associated mechanisms could pave the way for developing new neuroprotective strategies to modulate central and peripheral inflammation to lower risk for neurodegenerative diseases and possibly delay or halt progression.

Research progress of progranulin and related diseases of reproductive system

Progranulin in Regulation Mechanism of Glycolipid Metabolism and Renal Disease

Progranulin: A promising biomarker and therapeutic target for fibrotic diseases

Progranulin is essential for bone homeostasis and immunology

Progranulin Controls Sepsis Via C/EBPα-Regulated Il10 Transcription and Ubiquitin Ligase/Proteasome-Mediated Protein Degradation.

The Role of Pgrn in Alzheimer'S Disease

Progranulin (PGRN) as a regulator of inflammation and a critical factor in the immunopathogenesis of cardiovascular diseases

Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system

Progranulin: Physiological Function and Its Correlation with Tumorigenesis

Progress in research on possible role of progesterone receptor membrane component 1 (PGRMC1) in the mechanism of breast cancer development

Circulating PGRN is significantly associated with systemic insulin sensitivity and autophagic activity in metabolic syndrome.

Progranulin promotes proliferation, migration, and invasion of eutopic endometrial stromal cells in patients with endometriosis via the PI3K/Akt signaling pathway

Progranulin as a therapeutic target in neurodegenerative diseases

Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion

Pleiotropic Actions of PGRMC Proteins in Cancer

Progranulin deficiency associates with postmenopausal osteoporosis via increasing ubiquitination of estrogen receptor α

The role of progranulin in macrophages of a glioblastoma model

Analysis of the Biomarkers for Neurodegenerative Diseases in Aged Progranulin Deficient Mice

Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases

PGRN exacerbates the progression of non-small cell lung cancer via PI3K/AKT/Bcl-2 antiapoptotic signaling

Dysregulation of the Mitogen Granulin in Human Cancer Through the Mir-15/107 Microrna Gene Group.